M. Visini - Concepedia

Author

M. Visini

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

M Visini, M. Visini, Marilena Visini

Publications

405

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Alessandro Manzoni Hospital International Breast Cancer Study Group

About

M. Visini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	266
2	Pathology	2	2	23
3	Health Sciences	1	1	18
4	Gastroenterology	1	1	10
5	Neurology	1	1	13

M. Visini

Publications

389

Citations

H-Index

Page 1

	Year	Citations
Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group Emilio Bajetta, Roberto Buzzoni, Luigi Mariani, Annals of Oncology Surgical OncologyItalian TrialsGastrointestinal OncologyMedicineAdjuvant Chemotherapy	2002	137
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial Karin Ribi, Weixiu Luo, Jürg Bernhard, Journal of Clinical Oncology	2016	123
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group Maria Di Bartolomeo, Emilio Bajetta, Anna Maria Bochicchio, Annals of Oncology Endocrine OncologyOncologyItalian TrialsPhase Ii TrialMedicine	1995	88
Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study Antonio Ardizzoia, Mirko Acquati, Daniele Fagnani, Lung MedicineWeekly Low-dose DocetaxelBronchial NeoplasmPharmacotherapyCancer Treatment	2004	18
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)—first results from PathIES Valerie Speirs, Giuseppe Viale, Kelly Mousa, Annals of Oncology Clinical DisordersPrognostic EvaluationDisease ProgressionPrognosisClinical Epidemiology	2015	13
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group Emilio Bajetta, Maria Di Bartolomeo, Filippo de Braud, European Journal of Cancer Italian TrialsGastrointestinal OncologyMedicineGastroenterologyPathology	1994	10

Page 1